Stay updated on RO6958688 in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 in CEA+ Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedOnly internal revision labels were updated (v3.4.2 added; v3.4.1 removed); no user-facing study details or navigation were changed.SummaryDifference0.0%

- Check19 days agoChange Detected- Revision label updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4 added and Revision: v3.3.3 removed. This is a minor update that does not change the study details or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Locations section has been expanded with multiple study sites across the US, Canada, and Europe, and the page revision has been updated to v3.3.3, while the HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check91 days agoChange DetectedUpdated metadata: the PubMed auto-fill note is now present and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check98 days agoChange DetectedThe government funding lapse notice was removed from the page; core study details and locations remain unchanged.SummaryDifference0.3%

Stay in the know with updates to RO6958688 in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.